Retrouvez ci-dessous la veille bibliographique élaborée par notre groupe pour le mois d’avril 2024 !

• Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology | Lire l’article Archives of Cardiovascular Diseases
• Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer: JACC Family Series | Lire l’article JACC
• The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors: JACC: CardioOncology State-of-the-Art Review | Lire l’article JACC
• Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer: JACC Family Series | Lire l’article JACC
• Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control: Novel Therapeutic Target | Lire l’article JACC
• Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia | Lire l’article JACC
• Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials | Lire l’article JACC
• Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review | Lire l’article JACC
• Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis | Lire l’article JAMA Network